CDMO & Manufacturing

SMC Corporation specializes in pneumatic automation components tailored for the medical device and life science industries. They offer air cylinders, solenoid valves, linear actuators, grippers, and precision sensors to support pharmaceutical manufacturing and R&D automation. As a global leader with subsidiaries like SMC Corporation of America, they provide reliable products for industrial automation in every industrialized nation.

Aldevron is a CDMO specializing in plasmid DNA, mRNA, recombinant proteins, and gene editing components for cell and gene therapies from research to commercial scale. They offer GMP manufacturing, process and analytical development, LNP encapsulation, sterile fill/finish, and regulatory support including CMC and IND assistance. With over 25 years of experience, Aldevron ensures scalability and quality for viral and non-viral vectors.

Alfa Chemistry is an ISO 9001:2015 certified supplier of high-quality fine chemicals, reagents, building blocks, catalysts, and reference materials for pharmaceutical and biotechnology research. They provide custom synthesis, API research and development, drug discovery services, analytical testing, and computational solutions in solid-state chemistry. As a global CRO headquartered in New York, USA, they serve life sciences industries with laboratory services and high-tech instrumentation support worldwide.

Applied StemCell provides iPSC-derived cells, gene editing technologies like TARGATT™ and S-SELeCT™, and CRO/CDMO services for cell therapy development. They offer hypoimmunogenic hiPSCs, disease modeling, differentiation, and large DNA knock-ins up to 50 kb for precise genome engineering. Their products support drug screening, nonclinical studies, and GMP manufacturing from research to pre-IND stages.

Asahi Kasei Bioprocess offers virus removal filters like Planova™ and Microfilters BioOptimal™, along with fluid management solutions for biologics manufacturing. Through Asahi Kasei Life Science, established in April 2025, it provides CRO testing services via ViruSure and Bionique, and CDMO capabilities through Bionova Scientific. The company supports viral safety in cell culture media, downstream processing, and manufacturing for biopharmaceuticals and plasma-derived therapies.

Asahi Kasei Bioprocess, under Asahi Kasei Life Science established in April 2025, provides virus removal filters like Planova™ and Microfilters BioOptimal™, along with CRO testing services via ViruSure and Bionique, and CDMO services through Bionova Scientific. These solutions support viral safety in cell culture media, downstream biopharmaceutical manufacturing, and emerging biologics modalities. The company is expanding Planova™ production capacity with a new facility in Japan starting operations in 2030 to meet global demand.

Baumer provides sensors for reliable manufacturing and cleaning processes in food and beverage applications, with relevance to pharmaceutical packaging. Their sensors ensure precision in packaging industry operations. These technologies support consistent production standards applicable to pharma environments.

BOC Sciences supplies a wide range of research chemicals and biochemicals for pharmaceutical and biotech industries, including inhibitors, building blocks, GMP products, APIs, natural compounds, impurities, metabolites, ADCs, and chiral compounds. They offer integrated drug discovery services such as computational modeling, medicinal chemistry, custom synthesis, isotope labeling, bioconjugation, PEGylation, and analytical services, alongside CDMO capabilities for intermediates and APIs from preclinical to commercial stages. Headquartered in New York with production bases in China, they support global clients in life sciences R&D and manufacturing.

Bionova Scientific is a biologics contract development and manufacturing organization (CDMO) specializing in monoclonal antibodies and therapeutic proteins using mammalian cell culture processes. The company provides end-to-end services from discovery through cGMP commercial manufacturing, with capabilities in transient and stable protein production, process development, and plasmid DNA manufacturing. Operating state-of-the-art facilities in the San Francisco Bay Area and Houston, Texas, Bionova serves pharmaceutical companies developing complex next-generation antibody-based drugs and advanced therapies.

Biosynth supplies critical raw materials and contract manufacturing services for life sciences and diagnostics, specializing in carbohydrates, nucleosides, peptides, and enzyme substrates. The company offers custom synthesis, research products, and drug discovery support to secure supply chains. Their expertise includes bioconjugate manufacturing and custom peptide libraries for screening and characterization.

Bruker provides high-value analytical instruments including mass spectrometers, NMR systems, FT-IR/FT-NIR, X-ray, and Raman solutions for pharmaceutical and biopharma drug discovery, development, and manufacturing. These tools support small molecule and biopharmaceutical analysis, reaction monitoring, structural insights, and quality control to accelerate time-to-market and reduce risks. Bruker also offers software integrations and workflow solutions through partnerships, enhancing data processing and productivity in pharma R&D.

LGM Pharma provides comprehensive API sourcing, contract development and manufacturing (CDMO) services, and analytical testing for the pharmaceutical industry across the full drug product lifecycle. With cGMP facilities in California, Colorado, and Texas, they offer capabilities in liquids, suspensions, semi-solids, suppositories, endotoxin testing, rapid sterility testing, and stability services. Their investments enhance U.S.-based production and quality systems to meet regulatory standards.

BIOVECTRA is a global full-service CDMO specializing in small molecules, biologics, bioreagents, pDNA, and mRNA manufacturing for pharma and biotech. They provide end-to-end services from process development and cGMP production at kilo lab, pilot, and commercial scales to analytical testing and sterile fill-finish. Capabilities include microbial fermentation, synthetic chemistry, high potency containment, and lipid nanoparticle formulation, supporting projects from early clinical to commercial supply.

Cayman Chemical is a US-based CRO and CDMO offering chemistry and biology services to pharmaceutical, biotechnology, and academic markets. They provide custom chemical synthesis, medicinal chemistry, bioanalysis, assay development, and preclinical drug discovery support including psychedelics. Additional offerings include high-purity biochemicals, assay kits, antibodies, recombinant proteins, and cGMP manufacturing across US and EU facilities.

Autolomous develops critical manufacturing management systems and digital platforms for cell and gene therapy (CGT) production. Their AutoloMATE solution streamlines data management and automates workflows to help manufacturers reduce costs, scale operations, and deliver therapies to more patients. The company partners with CDMOs and advanced therapy manufacturers to implement digitized supply chain ecosystems and gain operational efficiencies.

Made Scientific, formerly BioCentriq, is a CDMO specializing in cell therapy development and manufacturing for pharmaceutical and biotech companies. It provides process and analytical development, GMP drug substance and product manufacturing, aseptic fill and finish, quality control testing, and workforce training. Facilities in New Jersey, including a 60,000 sq. ft. Princeton site with six ISO 7 cleanrooms, support clinical to commercial-scale production of modalities like CAR-T, NK cells, iPSC, and MSC therapies.

LenioBio develops ALiCE®, a scalable eukaryotic cell-free protein expression system that produces complex proteins within 24 hours. The platform enables rapid manufacturing of vaccine-relevant proteins, antibodies, virus-like particles, and membrane proteins, reducing traditional production timelines by approximately 75%. ALiCE® supports applications from research through clinical-scale biomanufacturing, with yields up to 3mg/ml and seamless scaling from microliter to liter volumes.

CellVec is a GMP-certified Contract Development and Manufacturing Organisation (CDMO) specializing in custom viral vectors for gene therapy and cellular therapies. Based in Singapore, the company provides lentiviral vector manufacturing services for preclinical and clinical applications, leveraging proprietary technology to achieve improved yields and process consistency. CellVec serves pharmaceutical and biotech clients developing cell-based immunotherapies and gene therapies for cancer and genetic diseases.

Celonic Group is a Switzerland-based biologics CDMO offering end-to-end drug substance development and manufacturing for monoclonal antibodies, bispecifics, and complex molecules. Services span cell line development, process optimization, clinical and commercial manufacturing up to 2,000L scale, with Swissmedic GMP certification. They leverage advanced technologies like perfusion bioprocessing and partner for fill-and-finish via strategic alliances.

Codexis specializes in enzyme engineering and biocatalysis solutions for pharmaceutical manufacturing, including custom enzymes for small molecule APIs via CodeEvolver® technology. Their ECO Synthesis™ platform enables scalable, sustainable production of RNAi therapeutics like siRNA through enzymatic synthesis, reducing waste and improving efficiency over chemical methods. With over 22 years of expertise, they support greener manufacturing for next-generation oligonucleotide therapies.

Creative Peptides is a CDMO specializing in high-quality peptide synthesis, modification, conjugation, and cGMP manufacturing for pharmaceutical and biotech applications. They offer custom peptide services from research-scale to large-scale production, including peptide libraries, analysis, and bioactive products supporting drug discovery and clinical development. With expertise in solid-phase and solution-phase synthesis, they serve global clients in peptide drug research, immunotherapy, and cosmetics.

Cytiva provides technologies and services for bioprocessing, including single-use systems, modular facilities, and automation tools to accelerate therapeutic development and manufacturing. Their portfolio features brands like ÄKTA, HyClone, and MabSelect, supporting upstream and downstream workflows with digital integration for efficiency and compliance. Enterprise solutions such as BioPark, KUBio, and FlexFactory enable scalable biomanufacturing and cell therapy production.

Protheragen supplies over 2,000 APIs with DMF/NDC availability, pharmaceutical intermediates, high-purity chemicals, excipients, and protein products for life sciences and pharma R&D and clinical trials. As an ISO9001-certified wholesaler with over 10 years of experience, they offer custom synthesis of complex intermediates including peptides, heterocycles, and chiral molecules, serving global markets from their US base. Their portfolio supports drug formulation, biopharma research, and nutraceutical production with reliable, high-quality materials.

Enzymit develops a cell-free biomanufacturing platform using AI-designed enzymes to produce high-purity hyaluronic acid (HA) and specialty carbohydrates from simple sugars. Their GMP-ready, animal-free process delivers pharmaceutical- and cosmetic-grade HA with selectable molecular weights from 20 kDa to 4 MDa, low endotoxin levels (≤0.05 EU/mg), and ≥99% purity. This technology scales linearly from kg to tonnes, reducing water, energy, and CO₂ compared to traditional fermentation.